{"id":"NCT05763875","sponsor":"Novartis Pharmaceuticals","briefTitle":"Efficacy and Safety of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-lowering Therapy.","officialTitle":"A Double-blind, Randomized, Placebo- and Active-Comparator Controlled Study to Evaluate the Efficacy of Inclisiran as Monotherapy in Patients With Primary Hypercholesterolemia Not Receiving Lipid-Lowering Therapy (VictORION-Mono)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2023-03-15","primaryCompletion":"2024-06-20","completion":"2024-06-20","firstPosted":"2023-03-10","resultsPosted":"2025-08-13","lastUpdate":"2025-08-13"},"enrollment":350,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia"],"interventions":[{"type":"DRUG","name":"Inclisiran","otherNames":["KJX839"]},{"type":"DRUG","name":"Ezetimibe","otherNames":["Sandoz ezetimibe"]},{"type":"DRUG","name":"Matching Placebo for Inclisiran","otherNames":["Placebo s.c."]},{"type":"DRUG","name":"Matching Placebo for Ezetimibe","otherNames":["Placebo p.o."]}],"arms":[{"label":"Inclisiran","type":"EXPERIMENTAL"},{"label":"Ezetimibe","type":"ACTIVE_COMPARATOR"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"CKJX839D12304 was a research study to determine if the study treatment, called inclisiran, in comparison to placebo and ezetimibe effectively reduces Low-Density Lipoprotein Cholesterol (LDL-C) as measured by percentage change from baseline to Day 150. This study was conducted in eligible participants with primary hypercholesterolemia not receiving any lipid-lowering therapy (LLT), with a 10-year Atherosclerotic Cardiovascular Disease (ASCVD) risk of less than 7.5%.","primaryOutcome":{"measure":"Percentage Change in Low-density Lipoprotein Cholesterol (LDL-C) From Baseline to Day 150","timeFrame":"Baseline, Day 150","effectByArm":[{"arm":"Inclisiran","deltaMin":-46.54,"sd":null},{"arm":"Ezetimibe","deltaMin":-11.17,"sd":null},{"arm":"Placebo","deltaMin":1.37,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG000 vs OG002","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":3},"locations":{"siteCount":42,"countries":["United States","Colombia","Germany","Hungary","Mexico"]},"refs":{"pmids":["40392667"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":174},"commonTop":["Nasopharyngitis","Urinary tract infection","COVID-19","Headache","Diarrhoea"]}}